Globeflex Capital L P Invests $417,000 in Veeva Systems Inc. $VEEV

Globeflex Capital L P acquired a new stake in shares of Veeva Systems Inc. (NYSE:VEEV) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 2,347 shares of the technology company’s stock, valued at approximately $417,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in VEEV. SHP Wealth Management bought a new position in shares of Veeva Systems during the 4th quarter valued at $26,000. Activest Wealth Management boosted its stake in shares of Veeva Systems by 3,175.0% in the 4th quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock worth $29,000 after buying an additional 127 shares during the last quarter. MV Capital Management Inc. bought a new stake in shares of Veeva Systems in the fourth quarter worth $30,000. Reflection Asset Management bought a new stake in shares of Veeva Systems in the fourth quarter worth $32,000. Finally, BOK Financial Private Wealth Inc. purchased a new stake in Veeva Systems during the fourth quarter valued at $33,000. Institutional investors own 88.20% of the company’s stock.

Veeva Systems Stock Performance

Shares of Veeva Systems stock opened at $247.38 on Wednesday. The company has a market capitalization of $40.18 billion, a P/E ratio of 44.10, a P/E/G ratio of 1.07 and a beta of 0.92. The company has a fifty day moving average of $201.60 and a 200 day moving average of $182.61. Veeva Systems Inc. has a fifty-two week low of $148.05 and a fifty-two week high of $310.50.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings results on Wednesday, June 3rd. The technology company reported $2.24 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The business had revenue of $882.95 million for the quarter, compared to analysts’ expectations of $857.73 million. During the same period last year, the firm earned $1.97 earnings per share. The business’s quarterly revenue was up 16.3% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. Analysts forecast that Veeva Systems Inc. will post 6.64 EPS for the current year.

Insider Activity

In related news, insider Thomas D. Schwenger sold 36,000 shares of the stock in a transaction dated Thursday, August 13th. The stock was sold at an average price of $250.23, for a total transaction of $9,008,280.00. Following the completion of the sale, the insider owned 19,449 shares in the company, valued at approximately $4,866,723.27. This trade represents a 64.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 10.60% of the company’s stock.

More Veeva Systems News

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Major Vault CRM customer wins strengthen Veeva’s competitive position. Biogen and Regeneron each committed to Veeva Vault CRM globally. The agreements support adoption of Veeva’s unified, AI-enabled commercial platform and provide further evidence of traction in the biopharmaceutical market. Veeva Vault CRM Selected by Biogen Veeva Vault CRM Selected by Regeneron
• Positive Sentiment: Truist said the wins reinforce Vault CRM’s market-leader status ahead of earnings. The analyst view suggests the customer additions could support future bookings, recurring revenue growth and broader cross-selling across Veeva’s life-sciences cloud products. Veeva’s Vault CRM Wins Reinforce Market-Leader Status Ahead of Earnings, Truist Says
• Positive Sentiment: Analyst sentiment remains favorable. Piper Sandler initiated coverage with an Overweight rating and a $295 price target, while Needham reiterated its Buy rating with a $270 target. Both targets imply additional upside from the referenced share price.
• Neutral Sentiment: Earnings are the immediate catalyst. Investors are looking for continued double-digit growth driven by Vault CRM, Falcon AI and R&D Cloud. The company’s latest reported quarter showed 16.3% year-over-year revenue growth and an earnings beat, raising expectations for another solid performance. What To Expect From Veeva Systems’s Q2 Earnings
• Negative Sentiment: Valuation leaves limited room for disappointment. Veeva trades at roughly 44 times earnings after a substantial rally, so any weakness in guidance, bookings or operating trends could prompt profit-taking. The stock’s decline ahead of results likely reflects investor caution while the market awaits confirmation of growth expectations.

Analysts Set New Price Targets

VEEV has been the topic of a number of recent research reports. Weiss Ratings raised Veeva Systems from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, August 12th. The Goldman Sachs Group cut their price target on Veeva Systems from $190.00 to $165.00 and set a “sell” rating for the company in a research note on Thursday, June 4th. Wells Fargo & Company upped their price target on shares of Veeva Systems from $317.00 to $320.00 and gave the company an “overweight” rating in a research report on Thursday, June 4th. Raymond James Financial reiterated an “outperform” rating and issued a $225.00 price objective on shares of Veeva Systems in a research note on Thursday, June 4th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $270.00 price objective on shares of Veeva Systems in a report on Monday. Nineteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $258.08.

About Veeva Systems

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.